Discontinuation report PANTOPRAZOLE SODIUM FOR INJECTION
Report ID | 241520 |
Drug Identification Number | 02306727 |
Brand name | PANTOPRAZOLE SODIUM FOR INJECTION |
Common or Proper name | PANTOPRAZOLE SODIUM FOR INJECTION |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | PANTOPRAZOLE |
Strength(s) | 40MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10LYVI |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | |
Actual discontinuation date | 2024-10-28 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2024-10-29 | English | Compare |
v2 | 2024-10-29 | English | Compare |
v3 | 2024-10-29 | French | Compare |
Showing 1 to 3 of 3